Skip to main content

. 1990 Nov;53(11):1015–1016. doi: 10.1136/jnnp.53.11.1015-a

Somatostatin in cerebrospinal fluid after generalised convulsions or cerebral infarction in humans.

H Cramer, K M Heitzelmann

PMCID: PMC488292 PMID: 2126553

1015

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Kato N., Higuchi T., Friesen H. G., Wada J. A. Changes of immunoreactive somatostatin and beta-endorphin content in rat brain after amygdaloid kindling. Life Sci. 1983 May 23;32(21):2415–2422. doi: 10.1016/0024-3205(83)90366-1. [DOI] [PubMed] [Google Scholar]
Kohler J., Schröter E., Cramer H. Somatostatin-like immunoreactivity in the cerebrospinal fluid of neurological patients. Arch Psychiatr Nervenkr (1970) 1982;231(6):503–508. doi: 10.1007/BF00343993. [DOI] [PubMed] [Google Scholar]
Pitkänen A., Jolkkonen J., Honkanen K. L., Riekkinen P. Effect of pentylenetetrazol-induced convulsions on somatostatin-like immunoreactivity in rat cerebrospinal fluid. Neuropeptides. 1987 Jan;9(1):19–24. doi: 10.1016/0143-4179(87)90027-8. [DOI] [PubMed] [Google Scholar]
Pitkänen A., Jolkkonen J., Riekkinen P. Beta-endorphin, somatostatin, and prolactin levels in cerebrospinal fluid of epileptic patients after generalised convulsion. J Neurol Neurosurg Psychiatry. 1987 Oct;50(10):1294–1297. doi: 10.1136/jnnp.50.10.1294. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES